COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,893 Articles (22,568 medRxiv, 8,325 bioRxiv)

Most recent first Previous |  Page 1172: Articles 11711-11720  | Next

Mental Health and Time Management Behavior among Students During COVID-19 Pandemic: Towards Persuasive Technology Design
Alhasani, M., Alkhawaji, A., Orji, R.
10.1101/2021.10.01.21264409 — Posted: 2021-10-01
Neonatal outcomes of preterm infants born during COVID-19 community lockdowns in Melbourne, Australia
Mulcahy, B., Rolnik, D., Matheson, A., Liu, Y., Palmer, K., Mol, B. W., Malhotra, A.
10.1101/2021.09.29.21264295 — Posted: 2021-10-01
Characteristics associated with COVID-19 vaccination status among staff and faculty of a large, diverse University in Los Angeles.
Nicolo, M., Kawaguchi, E., Ghanem-Uzqueda, A., Kim, A. E., Soto, D., Deva, S., Shanker, K. J., Rogers, C. J., Lee, R., Casagrande, Y., Gilliland, F., Van Orman, S., Klausner, J., Kovacs, A. A. Z., Conti, D. V., Hu, H., Unger, J. B.
10.1101/2021.09.29.21264315 — Posted: 2021-10-01 Discussion: Onsite
Importation Risk Stratification for COVID19 using Quantitative Serology
Williams, D. E.
10.1101/2021.09.29.21264323 — Posted: 2021-10-01
Assessing the Burden of COVID-19 in Developing Countries: Systematic Review, Meta-Analysis, and Public Policy Implications
Levin, A. T., Owusu-Boaitey, N., Pugh, S., Fosdick, B. K., Zwi, A. B., Malani, A., Soman, S., Besancon, L., Kashnitsky, I., Ganesh, S., McLaughlin, A., Song, G., Uhm, R., Meyerowitz-Katz, G.
10.1101/2021.09.29.21264325 — Posted: 2021-10-01
Modelling of COVID-19 pandemic vis-a-vis some socioeconomic factors
Oshinubi, K., rachdi, M., Demongeot, J.
10.1101/2021.09.30.21264356 — Posted: 2021-10-01
Effectiveness of mRNA-1273 against Delta, Mu, and other emerging variants
Bruxvoort, K., Sy, L. S., Qian, L., Ackerson, B. K., Luo, Y., Lee, G. S., Tian, Y., Florea, A., Aragones, M., Tubert, J. E., Takhar, H. S., Ku, J. H., Paila, Y. D., Talarico, C. A., Tseng, H. F.
10.1101/2021.09.29.21264199 — Posted: 2021-10-01
Reduced amplification efficiency of the RNA-dependent-RNA-polymerase (RdRp) target enables tracking of the Delta SARS-CoV-2 variant using routine diagnostic tests
Valley-Omar, Z., Marais, K., Iranzadeh, A., Naidoo, M., Korsman, S., Maponga, T., Hussey, H., Davies, M.-A., Boulle, A., Doolabh, D., Laubscher, M., Deetlefs, J., Maritz, J., Scott, L., Msomi, N., Tegally, H., de Oliveira, T., Bhiman, J., Williamson, C., Preiser, W., Hardie, D. R., Hsiao, N.-y.
10.1101/2021.10.01.21264408 — Posted: 2021-10-01
Evaluation of liver function tests and C-reactive protein in COVID-19 (SARS Cov-2) positive patients diagnosed by Real-time PCR
Khurshid, F., Iqbal, S., Mumtaz, M.
10.1101/2021.09.29.21264304 — Posted: 2021-10-01
Endemic Seasonal Coronavirus Neutralisation and COVID-19 severity
Wells, D. A., Cantoni, D., Mayora-Neto, M., Di Genova, C., Sampson, A., Ferrari, M., Carnell, G., Nadesalingam, A., Smith, P., Chan, A., Raddi, G., Castillo-Olivares, J., Baxendale, H., Temperton, N., Heeney, J.
10.1101/2021.09.29.21264328 — Posted: 2021-10-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).